Kintor Pharmaceutical Limited
KNTPF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$83,268 | -$83,799 | -$71,493 | -$849 |
| Dep. & Amort. | $12,658 | $8,887 | $8,740 | $9 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,980 | -$13,860 | $4,600 | -$11 |
| Change in WC | $0 | -$1,182 | $0 | $11 |
| Other Non-Cash | $58,120 | $77,741 | $42,800 | $666 |
| Operating Cash Flow | -$69,521 | -$88,419 | -$110,661 | -$174 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$900 | -$1,046 | -$492 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$14 | $888 |
| Inv. Sales/Matur. | $0 | $0 | $0 | -$883 |
| Other Inv. Act. | $2,915 | $3,791 | $412 | -$0 |
| Investing Cash Flow | $2,015 | $2,745 | -$94 | $3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$6,126 | -$14,315 | -$1,776 | -$9,627 |
| Stock Issued | $751 | $2 | $49 | $11 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$105 | -$317 | -$338 | $9,545 |
| Financing Cash Flow | -$5,480 | -$14,630 | -$2,065 | -$70 |
| Forex Effect | $162 | -$101 | -$900 | -$6 |
| Net Chg. in Cash | -$12,812 | -$24,199 | -$18,412 | -$247 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $20,247 | $44,446 | $62,858 | $691 |
| End Cash | $7,435 | $20,247 | $44,446 | $444 |
| Free Cash Flow | -$70,421 | -$89,465 | -$111,153 | -$176 |